New portable MRI could spot fatty liver in minutes

NCT ID NCT05986916

Ongoing Diagnosis Sponsor: University of California, San Diego Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study is testing a new portable device called LiverScope that uses MRI-like technology to measure fat in the liver. Researchers will compare it to standard MRI and FibroScan in 50 adults with known or suspected non-alcoholic fatty liver disease (NAFLD). Participants undergo a one-time visit with scans and a blood draw. The goal is to see if LiverScope can reliably diagnose liver fat without needing a full hospital MRI.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: LiverScope® exam (portable MRI device)
What this could lead to: If successful, this could provide a simpler, more accessible way to diagnose and monitor fatty liver disease without needing large hospital MRI machines.
What could go wrong: This is a small, early-stage study (50 participants) focused on comparing measurements, not on treatment. The device is not yet approved for clinical use, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NAFLD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

metabolic dysfunction-associated steatotic liver disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NAFLD NONALCOHOLIC FATTY LIVER

Contacts and locations

Locations

University of California San Diego

La Jolla, California, 92037, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.